Pi Bioferma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.60 M
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth -131.07%
- Ebitda -41.47%
- Net Worth -195.43%
- Total Assets -56.90%
About Pi Bioferma
Pi Bioferma Private Limited (PBPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 September 2020 (Four years and five months 15 days old ). Its registered office is in Udaipur, Rajasthan, India.
The Corporate was formerly known as Pi Enzachem Private Limited. The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.60 M, as per Ministry of Corporate Affairs (MCA) records.
Atulkumar Gupta and Rajnish Sarna serve as directors at the Company.
Company Details
- Location
Udaipur, Rajasthan, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24290RJ2020PTC070948
- Company No.
070948
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Sep 2020
- Date of AGM
18 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at Pi Bioferma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Atulkumar Gupta  | Director | 27-Apr-2023 | Current |
| Rajnish Sarna | Director | 11-Sep-2020 | Current |
Financial Performance of Pi Bioferma.
Pi Bioferma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 131.07% decrease in profit. The company's net worth observed a substantial decline by a decrease of 195.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pi Bioferma?
In 2022, Pi Bioferma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pi Industries LimitedRajnish Sarna is a mutual person
Pill Finance And Investments LimitedAtulkumar Gupta and Rajnish Sarna are mutual person
- Pi Life Science Research Limited
Atulkumar Gupta and Rajnish Sarna are mutual person
- Pi Fermachem Private Limited
Rajnish Sarna is a mutual person
- Pi Health Sciences Limited
Rajnish Sarna is a mutual person
- Jivagro Limited
Rajnish Sarna is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pi Bioferma?
Pi Bioferma has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pi Bioferma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pi Bioferma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
